Journey Medical Corporation (NASDAQ:DERM) Q2 2025 Earnings Call Transcript

Journey Medical Corporation (NASDAQ:DERM) Q2 2025 Earnings Call Transcript August 12, 2025

Journey Medical Corporation misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.07.

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical’s Second Quarter 2025 Financial Results and Corporate Update Conference Call. [Operator Instructions] Participants of this call are advised that the audio of this conference call is...